Human Immunodeficiency Virus Infection and Host Defense in the Lungs

 

 Buy Article Permissions and Reprints

Abstract

Immunosuppression associated with human immunodeficiency virus (HIV) infection impacts all components of host defense against pulmonary infection. Cells within the lung have altered immune function and are important reservoirs for HIV infection. The host immune response to infected lung cells further compromises responses to a secondary pathogenic insult. In the upper respiratory tract, mucociliary function is impaired and there are decreased levels of salivary immunoglobulin A. Host defenses in the lower respiratory tract are controlled by alveolar macrophages, lymphocytes, and polymorphonuclear leukocytes. As HIV infection progresses, lung CD4 T cells are reduced in number causing a lack of activation signals from CD4 T cells and impaired defense by macrophages. CD8 T cells, on the other hand, are increased in number and cause lymphocytic alveolitis. Specific antibody responses by B-lymphocytes are decreased and opsonization of microorganisms is impaired. These observed defects in host defense of the respiratory tract explain the susceptibility of HIV-infected persons for oropharyngeal candidiasis, bacterial pneumonia, Pneumocystis pneumonia, and other opportunistic infections.

• References

• 1 HIV in the United States | Statistics Overview | Statistics Center | HIV/AIDS | CDC. Estimated HIV incidence among adults and adolescents in the United States, 2007–2010. HIV Surveillance Supplemental Report 2012;17(4). 2015. Available at http://www.cdc.gov/hiv/statistics/basics/ataglance.html
  PubMedGoogle Scholar
• 2 Beck JM. Abnormalities in host defense associated with HIV infection. Clin Chest Med 2013; 34 (2) 143-153
  CrossrefPubMedGoogle Scholar
• 3 White NC, Agostini C, Israel-Biet D, Semenzato G, Clarke JR. The growth and the control of human immunodeficiency virus in the lung: implications for highly active antiretroviral therapy. Eur J Clin Invest 1999; 29 (11) 964-972
  CrossrefPubMedGoogle Scholar
• 4 Crowe SM, Carlin JB, Stewart KI, Lucas CR, Hoy JF. Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons. J Acquir Immune Defic Syndr 1991; 4 (8) 770-776
  PubMedGoogle Scholar
• 5 Shellito JE. Failure of host defenses in human immunodeficiency virus. Semin Respir Crit Care Med 2004; 25 (1) 73-84
  Article in Thieme ConnectPubMedGoogle Scholar
• 6 Kolls JK. CD4(+) T-cell subsets and host defense in the lung. Immunol Rev 2013; 252 (1) 156-163
  CrossrefPubMedGoogle Scholar
• 7 Beck JM. The immunocompromised host: HIV infection. Proc Am Thorac Soc 2005; 2 (5) 423-427
  CrossrefPubMedGoogle Scholar
• 8 Beck JM, Rosen MJ, Peavy HH. Pulmonary complications of HIV infection. Report of the Fourth NHLBI Workshop. Am J Respir Crit Care Med 2001; 164 (11) 2120-2126
  CrossrefPubMedGoogle Scholar
• 9 Rosen MJ. Pulmonary complications of HIV infection. Respirology 2008; 13 (2) 181-190
  CrossrefPubMedGoogle Scholar
• 10 Murray JF. Epidemiology of human immunodeficiency virus-associated pulmonary disease. Clin Chest Med 2013; 34 (2) 165-179
  CrossrefPubMedGoogle Scholar
• 11 Sarkar P, Rasheed HF. Clinical review: respiratory failure in HIV-infected patients—a changing picture. Crit Care 2013; 17 (3) 228
  CrossrefPubMedGoogle Scholar
• 12 Naif HM. Pathogenesis of HIV infection. Infect Dis Rep 2013; 5 (X) (Suppl. 01) e6
  PubMedGoogle Scholar
• 13 Milgrim LM, Rubin JS, Small CB. Mucociliary clearance abnormalities in the HIV-infected patient: a precursor to acute sinusitis. Laryngoscope 1995; 105 (11) 1202-1208
  CrossrefPubMedGoogle Scholar
• 14 Montella F, Pezzotti P, Di Sora F, Recchia O, Lauria F, Rezza G. Improving the prognostic value of CD4+ count using IgA and clinical signs in HIV-seropositive i.v. drug users. Infection 1997; 25 (2) 117-120
  CrossrefPubMedGoogle Scholar
• 15 Gordon SB, Read RC. Macrophage defences against respiratory tract infections. Br Med Bull 2002; 61: 45-61
  CrossrefPubMedGoogle Scholar
• 16 Mosser DM. Receptors on phagocytic cells involved in microbial recognition. Immunol Ser 1994; 60: 99-114
  PubMedGoogle Scholar
• 17 Iordanskiy S, Santos S, Bukrinsky M. Nature, nurture and HIV: the effect of producer cell on viral physiology. Virology 2013; 443 (2) 208-213
  CrossrefPubMedGoogle Scholar
• 18 Abbas W, Herbein G. T-cell signaling in HIV-1 infection. Open Virol J 2013; 7: 57-71
  CrossrefPubMedGoogle Scholar
• 19 Kumar A, Herbein G. The macrophage: a therapeutic target in HIV-1 infection. Mol Cell Ther 2014; 2: 10
  PubMedGoogle Scholar
• 20 Crowe SM, Mills J, Kirihara J, Boothman J, Marshall JA, McGrath MS. Full-length recombinant CD4 and recombinant gp120 inhibit fusion between HIV infected macrophages and uninfected CD4-expressing T-lymphoblastoid cells. AIDS Res Hum Retroviruses 1990; 6 (8) 1031-1037
  PubMedGoogle Scholar
• 21 Crowe SM, Mills J, Elbeik T , et al. Human immunodeficiency virus-infected monocyte-derived macrophages express surface gp120 and fuse with CD4 lymphoid cells in vitro: a possible mechanism of T lymphocyte depletion in vivo. Clin Immunol Immunopathol 1992; 65 (2) 143-151
  CrossrefPubMedGoogle Scholar
• 22 Groot F, Welsch S, Sattentau QJ. Efficient HIV-1 transmission from macrophages to T cells across transient virological synapses. Blood 2008; 111 (9) 4660-4663
  CrossrefPubMedGoogle Scholar
• 23 Gendelman HE, Orenstein JM, Martin MA , et al. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J Exp Med 1988; 167 (4) 1428-1441
  CrossrefPubMedGoogle Scholar
• 24 Carter CA, Ehrlich LS. Cell biology of HIV-1 infection of macrophages. Annu Rev Microbiol 2008; 62: 425-443
  CrossrefPubMedGoogle Scholar
• 25 Gavegnano C, Kennedy EM, Kim B, Schinazi RF. The impact of macrophage nucleotide pools on HIV-1 reverse transcription, viral replication, and the development of novel antiviral agents. Mol Biol Int 2012; 2012: 625983
  PubMedGoogle Scholar
• 26 Schmidtmayerova H, Alfano M, Nuovo G, Bukrinsky M. Human immunodeficiency virus type 1 T-lymphotropic strains enter macrophages via a CD4- and CXCR4-mediated pathway: replication is restricted at a postentry level. J Virol 1998; 72 (6) 4633-4642
  PubMedGoogle Scholar
• 27 Sheehy AM, Gaddis NC, Choi JD, Malim MH. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 2002; 418 (6898) 646-650
  CrossrefPubMedGoogle Scholar
• 28 Neil SJ, Zang T, Bieniasz PD. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 2008; 451 (7177) 425-430
  CrossrefPubMedGoogle Scholar
• 29 Hrecka K, Hao C, Gierszewska M , et al. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 2011; 474 (7353) 658-661
  CrossrefPubMedGoogle Scholar
• 30 Lahouassa H, Daddacha W, Hofmann H , et al. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat Immunol 2012; 13 (3) 223-228
  CrossrefPubMedGoogle Scholar
• 31 Herbein G, Gras G, Khan KA, Abbas W. Macrophage signaling in HIV-1 infection. Retrovirology 2010; 7: 34
  CrossrefPubMedGoogle Scholar
• 32 Das SR, Jameel S. Biology of the HIV Nef protein. Indian J Med Res 2005; 121 (4) 315-332
  PubMedGoogle Scholar
• 33 Lamers SL, Fogel GB, Singer EJ , et al. HIV-1 Nef in macrophage-mediated disease pathogenesis. Int Rev Immunol 2012; 31 (6) 432-450
  CrossrefPubMedGoogle Scholar
• 34 Lama J, Mangasarian A, Trono D. Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner. Curr Biol 1999; 9 (12) 622-631
  CrossrefPubMedGoogle Scholar
• 35 Foster JL, Garcia JV. HIV-1 Nef: at the crossroads. Retrovirology 2008; 5: 84
  CrossrefPubMedGoogle Scholar
• 36 Noonan D, Albini A. From the outside in: extracellular activities of HIV Tat. Adv Pharmacol 2000; 48: 229-250
  PubMedGoogle Scholar
• 37 Gautier VW, Gu L, O'Donoghue N, Pennington S, Sheehy N, Hall WW. In vitro nuclear interactome of the HIV-1 Tat protein. Retrovirology 2009; 6: 47
  CrossrefPubMedGoogle Scholar
• 38 Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005; 308 (5726) 1314-1318
  CrossrefPubMedGoogle Scholar
• 39 McArthur JC, Hoover DR, Bacellar H , et al. Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. Neurology 1993; 43 (11) 2245-2252
  CrossrefPubMedGoogle Scholar
• 40 Emerman M. HIV-1, Vpr and the cell cycle. Curr Biol 1996; 6 (9) 1096-1103
  CrossrefPubMedGoogle Scholar
• 41 Dragic T, Litwin V, Allaway GP , et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996; 381 (6584) 667-673
  CrossrefPubMedGoogle Scholar
• 42 Subbramanian RA, Kessous-Elbaz A, Lodge R , et al. Human immunodeficiency virus type 1 Vpr is a positive regulator of viral transcription and infectivity in primary human macrophages. J Exp Med 1998; 187 (7) 1103-1111
  CrossrefPubMedGoogle Scholar
• 43 Vodicka MA, Koepp DM, Silver PA, Emerman M. HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection. Genes Dev 1998; 12 (2) 175-185
  CrossrefPubMedGoogle Scholar
• 44 Jacquot G, Le Rouzic E, David A , et al. Localization of HIV-1 Vpr to the nuclear envelope: impact on Vpr functions and virus replication in macrophages. Retrovirology 2007; 4: 84
  CrossrefPubMedGoogle Scholar
• 45 Varin A, Decrion AZ, Sabbah E , et al. Synthetic Vpr protein activates activator protein-1, c-Jun N-terminal kinase, and NF-kappaB and stimulates HIV-1 transcription in promonocytic cells and primary macrophages. J Biol Chem 2005; 280 (52) 42557-42567
  CrossrefPubMedGoogle Scholar
• 46 Faherty CS, Maurelli AT. Staying alive: bacterial inhibition of apoptosis during infection. Trends Microbiol 2008; 16 (4) 173-180
  CrossrefPubMedGoogle Scholar
• 47 Elliott MR, Chekeni FB, Trampont PC , et al. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 2009; 461 (7261) 282-286
  CrossrefPubMedGoogle Scholar
• 48 Hume DA. Bring out your dead. Nat Immunol 2008; 9 (1) 12-14
  CrossrefPubMedGoogle Scholar
• 49 Kono H, Rock KL. How dying cells alert the immune system to danger. Nat Rev Immunol 2008; 8 (4) 279-289
  Google Scholar
• 50 Martin CJ, Booty MG, Rosebrock TR , et al. Efferocytosis is an innate antibacterial mechanism. Cell Host Microbe 2012; 12 (3) 289-300
  CrossrefPubMedGoogle Scholar
• 51 Torre D, Gennero L, Baccino FM, Speranza F, Biondi G, Pugliese A. Impaired macrophage phagocytosis of apoptotic neutrophils in patients with human immunodeficiency virus type 1 infection. Clin Diagn Lab Immunol 2002; 9 (5) 983-986
  PubMedGoogle Scholar
• 52 Martin II WJ, Pasula R. Role of alveolar macrophages in host defense against Pneumocystis carinii . Am J Respir Cell Mol Biol 2000; 23 (4) 434-435
  CrossrefPubMedGoogle Scholar
• 53 Mwandumba HC, Squire SB, White SA , et al. Alveolar macrophages from HIV-infected patients with pulmonary tuberculosis retain the capacity to respond to stimulation by lipopolysaccharide. Microbes Infect 2007; 9 (9) 1053-1060
  CrossrefPubMedGoogle Scholar
• 54 Koziel H, Li X, Armstrong MY, Richards FF, Rose RM. Alveolar macrophages from human immunodeficiency virus-infected persons demonstrate impaired oxidative burst response to Pneumocystis carinii in vitro. Am J Respir Cell Mol Biol 2000; 23 (4) 452-459
  CrossrefPubMedGoogle Scholar
• 55 Peebles Jr RS, Graham BS. Viruses, dendritic cells and the lung. Respir Res 2001; 2 (4) 245-249
  CrossrefPubMedGoogle Scholar
• 56 Posch W, Lass-Floörl C, Wilflingseder D. Role of dendritic cell subsets on HIV-specific immunity, current perspectives in HIV infection. In: Saxena SK, ed. 2013. ISBN: 978-953-51-1057-6, InTech. DOI: 10.5772/52744. Available from: http://www.intechopen.com/books/current-perspectives-in-hiv-infection/role-of-dendritic-cell-subsets-on-hiv-specific-immunity
  PubMedGoogle Scholar
• 57 Randolph GJ, Ochando J, Partida-Sánchez S. Migration of dendritic cell subsets and their precursors. Annu Rev Immunol 2008; 26: 293-316
  CrossrefPubMedGoogle Scholar
• 58 Siegal FP, Kadowaki N, Shodell M , et al. The nature of the principal type 1 interferon-producing cells in human blood. Science 1999; 284 (5421) 1835-1837
  CrossrefPubMedGoogle Scholar
• 59 Fanning SL, George TC, Feng D , et al. Receptor cross-linking on human plasmacytoid dendritic cells leads to the regulation of IFN-alpha production. J Immunol 2006; 177 (9) 5829-5839
  CrossrefPubMedGoogle Scholar
• 60 Fitzgerald-Bocarsly P, Dai J, Singh S. Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history. Cytokine Growth Factor Rev 2008; 19 (1) 3-19
  CrossrefPubMedGoogle Scholar
• 61 Fazekas de St Groth B. The evolution of self-tolerance: a new cell arises to meet the challenge of self-reactivity. Immunol Today 1998; 19 (10) 448-454
  CrossrefPubMedGoogle Scholar
• 62 Banchereau J, Briere F, Caux C , et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18: 767-811
  CrossrefPubMedGoogle Scholar
• 63 Lambrecht BN, Prins JB, Hoogsteden HC. Lung dendritic cells and host immunity to infection. Eur Respir J 2001; 18 (4) 692-704
  PubMedGoogle Scholar
• 64 Manches O, Frleta D, Bhardwaj N. Dendritic cells in progression and pathology of HIV infection. Trends Immunol 2014; 35 (3) 114-122
  CrossrefPubMedGoogle Scholar
• 65 Geijtenbeek TB, Kwon DS, Torensma R , et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000; 100 (5) 587-597
  CrossrefPubMedGoogle Scholar
• 66 Cameron PU, Freudenthal PS, Barker JM, Gezelter S, Inaba K, Steinman RM. Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells. Science 1992; 257 (5068) 383-387
  CrossrefPubMedGoogle Scholar
• 67 Pope M, Betjes MG, Romani N , et al. Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell 1994; 78 (3) 389-398
  CrossrefPubMedGoogle Scholar
• 68 Sheehy AM, Gaddis NC, Malim MH. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat Med 2003; 9 (11) 1404-1407
  CrossrefPubMedGoogle Scholar
• 69 Grütter MG, Luban J. TRIM5 structure, HIV-1 capsid recognition, and innate immune signaling. Curr Opin Virol 2012; 2 (2) 142-150
  CrossrefPubMedGoogle Scholar
• 70 Sabado RL, O'Brien M, Subedi A , et al. Evidence of dysregulation of dendritic cells in primary HIV infection. Blood 2010; 116 (19) 3839-3852
  CrossrefPubMedGoogle Scholar
• 71 Donaghy H, Gazzard B, Gotch F, Patterson S. Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1. Blood 2003; 101 (11) 4505-4511
  CrossrefPubMedGoogle Scholar
• 72 Kodama A, Tanaka R, Zhang LF , et al. Impairment of in vitro generation of monocyte-derived human dendritic cells by inactivated human immunodeficiency virus-1: Involvement of type I interferon produced from plasmacytoid dendritic cells. Hum Immunol 2010; 71 (6) 541-550
  CrossrefPubMedGoogle Scholar
• 73 Swiecki M, Wang Y, Vermi W, Gilfillan S, Schreiber RD, Colonna M. Type I interferon negatively controls plasmacytoid dendritic cell numbers in vivo. J Exp Med 2011; 208 (12) 2367-2374
  CrossrefPubMedGoogle Scholar
• 74 Ahmed Z, Kawamura T, Shimada S, Piguet V. The role of human dendritic cells in HIV-1 infection. J Invest Dermatol 2015; 135 (5) 1225-1233
  CrossrefPubMedGoogle Scholar
• 75 Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392 (6673) 245-252
  CrossrefPubMedGoogle Scholar
• 76 Turville SG, Santos JJ, Frank I , et al. Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells. Blood 2004; 103 (6) 2170-2179
  CrossrefPubMedGoogle Scholar
• 77 Wu L, KewalRamani VN. Dendritic-cell interactions with HIV: infection and viral dissemination. Nat Rev Immunol 2006; 6 (11) 859-868
  CrossrefPubMedGoogle Scholar
• 78 Garcia E, Pion M, Pelchen-Matthews A , et al. HIV-1 trafficking to the dendritic cell-T-cell infectious synapse uses a pathway of tetraspanin sorting to the immunological synapse. Traffic 2005; 6 (6) 488-501
  CrossrefPubMedGoogle Scholar
• 79 Choudhuri K, Llodrá J, Roth EW , et al. Polarized release of T-cell-receptor-enriched microvesicles at the immunological synapse. Nature 2014; 507 (7490) 118-123
  CrossrefPubMedGoogle Scholar
• 80 Borregaard N. Neutrophils, from marrow to microbes. Immunity 2010; 33 (5) 657-670
  CrossrefPubMedGoogle Scholar
• 81 Gabelloni ML, Trevani AS, Sabatté J, Geffner J. Mechanisms regulating neutrophil survival and cell death. Semin Immunopathol 2013; 35 (4) 423-437
  CrossrefPubMedGoogle Scholar
• 82 Ellis M, Gupta S, Galant S , et al. Impaired neutrophil function in patients with AIDS or AIDS-related complex: a comprehensive evaluation. J Infect Dis 1988; 158 (6) 1268-1276
  CrossrefPubMedGoogle Scholar
• 83 Lazzarin A, Uberti Foppa C, Galli M , et al. Impairment of polymorphonuclear leucocyte function in patients with acquired immunodeficiency syndrome and with lymphadenopathy syndrome. Clin Exp Immunol 1986; 65 (1) 105-111
  PubMedGoogle Scholar
• 84 Murphy PM, Lane HC, Fauci AS, Gallin JI. Impairment of neutrophil bactericidal capacity in patients with AIDS. J Infect Dis 1988; 158 (3) 627-630
  CrossrefPubMedGoogle Scholar
• 85 Nielsen H, Kharazmi A, Faber V. Blood monocyte and neutrophil functions in the acquired immune deficiency syndrome. Scand J Immunol 1986; 24 (3) 291-296
  PubMedGoogle Scholar
• 86 Pitrak DL, Bak PM, DeMarais P, Novak RM, Andersen BR. Depressed neutrophil superoxide production in human immunodeficiency virus infection. J Infect Dis 1993; 167 (6) 1406-1410
  CrossrefPubMedGoogle Scholar
• 87 Pitrak DL, Tsai HC, Mullane KM, Sutton SH, Stevens P. Accelerated neutrophil apoptosis in the acquired immunodeficiency syndrome. J Clin Invest 1996; 98 (12) 2714-2719
  CrossrefPubMedGoogle Scholar
• 88 Fichtenbaum CJ, Woeltje KF, Powderly WG. Serious Pseudomonas aeruginosa infections in patients infected with human immunodeficiency virus: a case-control study. Clin Infect Dis 1994; 19 (3) 417-422
  CrossrefPubMedGoogle Scholar
• 89 Day CL, Kaufmann DE, Kiepiela P , et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006; 443 (7109) 350-354
  CrossrefPubMedGoogle Scholar
• 90 Brenchley JM, Karandikar NJ, Betts MR , et al. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 2003; 101 (7) 2711-2720
  CrossrefPubMedGoogle Scholar
• 91 El-Far M, Halwani R, Said E , et al. T-cell exhaustion in HIV infection. Curr HIV/AIDS Rep 2008; 5 (1) 13-19
  CrossrefPubMedGoogle Scholar
• 92 Rosignoli G, Cranage A, Burton C , et al. Expression of PD-L1, a marker of disease status, is not reduced by HAART in aviraemic patients. AIDS 2007; 21 (10) 1379-1381
  CrossrefPubMedGoogle Scholar
• 93 Freeman GJ, Long AJ, Iwai Y , et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 2000; 192 (7) 1027-1034
  CrossrefPubMedGoogle Scholar
• 94 Carter L, Fouser LA, Jussif J , et al. PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2. Eur J Immunol 2002; 32 (3) 634-643
  CrossrefPubMedGoogle Scholar
• 95 Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 2008; 26: 677-704
  CrossrefPubMedGoogle Scholar
• 96 Wherry EJ, Ha SJ, Kaech SM , et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 2007; 27 (4) 670-684
  CrossrefPubMedGoogle Scholar
• 97 Bowers NL, Helton ES, Huijbregts RP, Goepfert PA, Heath SL, Hel Z. Immune suppression by neutrophils in HIV-1 infection: role of PD-L1/PD-1 pathway. PLoS Pathog 2014; 10 (3) e1003993
  CrossrefPubMedGoogle Scholar
• 98 Mortha A, Diefenbach A. Natural killer cell receptor-expressing innate lymphocytes: more than just NK cells. Cell Mol Life Sci 2011; 68 (21) 3541-3555
  CrossrefPubMedGoogle Scholar
• 99 Shi F-D, Ljunggren H-G, La Cava A, Van Kaer L. Organ-specific features of natural killer cells. Nat Rev Immunol 2011; 11 (10) 658-671
  CrossrefPubMedGoogle Scholar
• 100 Stegmann KA, Björkström NK, Veber H , et al. Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection. Gastroenterology 2010; 138 (5) 1885-1897
  CrossrefPubMedGoogle Scholar
• 101 Kelly MN, Zheng M, Ruan S, Kolls J, D'Souza A, Shellito JE. Memory CD4+ T cells are required for optimal NK cell effector functions against the opportunistic fungal pathogen Pneumocystis murina . J Immunol 2013; 190 (1) 285-295
  CrossrefPubMedGoogle Scholar
• 102 Moll M, Snyder-Cappione J, Spotts G, Hecht FM, Sandberg JK, Nixon DF. Expansion of CD1d-restricted NKT cells in patients with primary HIV-1 infection treated with interleukin-2. Blood 2006; 107 (8) 3081-3083
  CrossrefPubMedGoogle Scholar
• 103 Sandberg JK, Fast NM, Palacios EH , et al. Selective loss of innate CD4(+) V α 24 natural killer T cells in human immunodeficiency virus infection. J Virol 2002; 76 (15) 7528-7534
  CrossrefPubMedGoogle Scholar
• 104 Motsinger A, Haas DW, Stanic AK, Van Kaer L, Joyce S, Unutmaz D. CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection. J Exp Med 2002; 195 (7) 869-879
  CrossrefPubMedGoogle Scholar
• 105 van der Vliet HJ, von Blomberg BM, Hazenberg MD , et al. Selective decrease in circulating V alpha 24+V beta 11+ NKT cells during HIV type 1 infection. J Immunol 2002; 168 (3) 1490-1495
  CrossrefPubMedGoogle Scholar
• 106 Giorgi JV, Hultin LE, McKeating JA , et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 1999; 179 (4) 859-870
  CrossrefPubMedGoogle Scholar
• 107 Sousa AE, Carneiro J, Meier-Schellersheim M, Grossman Z, Victorino RM. CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J Immunol 2002; 169 (6) 3400-3406
  CrossrefPubMedGoogle Scholar
• 108 Taylor JM, Fahey JL, Detels R, Giorgi JV. CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: which to choose and how to use. J Acquir Immune Defic Syndr 1989; 2 (2) 114-124
  PubMedGoogle Scholar
• 109 Zaman MM, Recco RA, Raguthu L, Likki S, Reddy S. Characteristics of HIV-1-infected patients with CD4:CD8 lymphocyte ratio normalization on antiretroviral therapy. AIDS Patient Care STDS 2000; 14 (12) 647-649
  CrossrefPubMedGoogle Scholar
• 110 Margolick JB, Gange SJ, Detels R, O'Gorman MR, Rinaldo Jr CR, Lai S. Impact of inversion of the CD4/CD8 ratio on the natural history of HIV-1 infection. J Acquir Immune Defic Syndr 2006; 42 (5) 620-626
  CrossrefPubMedGoogle Scholar
• 111 Pahwa S, Read JS, Yin W , et al; Women and Infants Transmission Study. CD4+/CD8+ T cell ratio for diagnosis of HIV-1 infection in infants: Women and Infants Transmission Study. Pediatrics 2008; 122 (2) 331-339
  CrossrefPubMedGoogle Scholar
• 112 Amadori A, Zamarchi R, De Silvestro G , et al. Genetic control of the CD4/CD8 T-cell ratio in humans. Nat Med 1995; 1 (12) 1279-1283
  CrossrefPubMedGoogle Scholar
• 113 Tang J, Li X, Price MA , et al. CD4:CD8 lymphocyte ratio as a quantitative measure of immunologic health in HIV-1 infection: findings from an African cohort with prospective data. Front Microbiol 2015; 6: 670
  PubMedGoogle Scholar
• 114 Neff CP, Chain JL, MaWhinney S , et al. Lymphocytic alveolitis is associated with the accumulation of functionally impaired HIV-specific T cells in the lung of antiretroviral therapy-naive subjects. Am J Respir Crit Care Med 2015; 191 (4) 464-473
  CrossrefPubMedGoogle Scholar
• 115 Twigg HL, Soliman DM, Day RB , et al. Lymphocytic alveolitis, bronchoalveolar lavage viral load, and outcome in human immunodeficiency virus infection. Am J Respir Crit Care Med 1999; 159 (5, Pt 1) 1439-1444
  CrossrefPubMedGoogle Scholar
• 116 Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995; 373 (6510) 123-126
  CrossrefPubMedGoogle Scholar
• 117 Nakayama-Hosoya K, Ishida T, Youngblood B , et al. Epigenetic repression of interleukin 2 expression in senescent CD4+ T cells during chronic HIV type 1 infection. J Infect Dis 2015; 211 (1) 28-39
  CrossrefPubMedGoogle Scholar
• 118 Nakayama K, Nakamura H, Koga M , et al. Imbalanced production of cytokines by T cells associates with the activation/exhaustion status of memory T cells in chronic HIV type 1 infection. AIDS Res Hum Retroviruses 2012; 28 (7) 702-714
  CrossrefPubMedGoogle Scholar
• 119 Giuliani E, Vassena L, Cerboni C, Doria M. Release of soluble ligands for the activating NKG2D receptor: one more immune evasion strategy evolved by HIV-1?. Curr Drug Targets 2015; 17 (1) 54-64
  CrossrefPubMedGoogle Scholar
• 120 Fry TJ, Mackall CL. The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. J Immunol 2005; 174 (11) 6571-6576
  CrossrefPubMedGoogle Scholar
• 121 Schluns KS, Kieper WC, Jameson SC, Lefrançois L. Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo. Nat Immunol 2000; 1 (5) 426-432
  CrossrefPubMedGoogle Scholar
• 122 Tan JT, Dudl E, LeRoy E , et al. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci U S A 2001; 98 (15) 8732-8737
  CrossrefPubMedGoogle Scholar
• 123 Tan JT, Ernst B, Kieper WC, LeRoy E, Sprent J, Surh CD. Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. J Exp Med 2002; 195 (12) 1523-1532
  CrossrefPubMedGoogle Scholar
• 124 Lang KS, Recher M, Navarini AA , et al. Inverse correlation between IL-7 receptor expression and CD8 T cell exhaustion during persistent antigen stimulation. Eur J Immunol 2005; 35 (3) 738-745
  CrossrefPubMedGoogle Scholar
• 125 Koesters SA, Alimonti JB, Wachihi C , et al. IL-7Ralpha expression on CD4+ T lymphocytes decreases with HIV disease progression and inversely correlates with immune activation. Eur J Immunol 2006; 36 (2) 336-344
  CrossrefPubMedGoogle Scholar
• 126 Boutboul F, Puthier D, Appay V , et al. Modulation of interleukin-7 receptor expression characterizes differentiation of CD8 T cells specific for HIV, EBV and CMV. AIDS 2005; 19 (17) 1981-1986
  CrossrefPubMedGoogle Scholar
• 127 Golden-Mason L, Burton Jr JR, Castelblanco N , et al. Loss of IL-7 receptor alpha-chain (CD127) expression in acute HCV infection associated with viral persistence. Hepatology 2006; 44 (5) 1098-1109
  PubMedGoogle Scholar
• 128 Crawley AM, Angel JB. The influence of HIV on CD127 expression and its potential implications for IL-7 therapy. Semin Immunol 2012; 24 (3) 231-240
  CrossrefPubMedGoogle Scholar
• 129 Moir S, Fauci AS. B cells in HIV infection and disease. Nat Rev Immunol 2009; 9 (4) 235-245
  CrossrefPubMedGoogle Scholar
• 130 Wilkes DS, Weissler JC. Alloantigen-induced immunoglobulin production in human lung: differential effects of accessory cell populations on IgG synthesis. Am J Respir Cell Mol Biol 1994; 10 (3) 339-346
  CrossrefPubMedGoogle Scholar
• 131 Twigg III HL, Spain BA, Soliman DM, Bowen LK, Heidler KM, Wilkes DS. Impaired IgG production in the lungs of HIV-infected individuals. Cell Immunol 1996; 170 (1) 127-133
  CrossrefPubMedGoogle Scholar
• 132 Lane HC, Masur H, Edgar LC, Whalen G, Rook AH, Fauci AS. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 1983; 309 (8) 453-458
  CrossrefPubMedGoogle Scholar
• 133 Baughman RP, Thorpe JE, Staneck J, Rashkin M, Frame PT. Use of the protected specimen brush in patients with endotracheal or tracheostomy tubes. Chest 1987; 91 (2) 233-236
  CrossrefPubMedGoogle Scholar
• 134 Thorpe JE, Baughman RP, Frame PT, Wesseler TA, Staneck JL. Bronchoalveolar lavage for diagnosing acute bacterial pneumonia. J Infect Dis 1987; 155 (5) 855-861
  CrossrefPubMedGoogle Scholar
• 135 Lozupone C, Cota-Gomez A, Palmer BE , et al; Lung HIV Microbiome Project. Widespread colonization of the lung by Tropheryma whipplei in HIV infection. Am J Respir Crit Care Med 2013; 187 (10) 1110-1117
  CrossrefPubMedGoogle Scholar